Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.8
-99.06%
40%
—
16.72%
80%
—
5 Years
Score3.8
Net Growth-99.06%
Net Trend40%
Net Income Consistency—
Rev Growth16.72%
Rev Trend80%
Revenue Consistency—
Caribou Biosciences Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 9M to $ 11M and net income went from -$ 66M to -$ 148M. Revenue increased in 80% of the years measured; net income in 40%.
Caribou Biosciences Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.70 | — |
1 Year2025-08-12 | $ 1.79 | -5.03% |
5 Years2021-08-12 | $ 23.23 | -92.68% |
All Time2021-07-23 | $ 16.32 | -89.58% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-23 |
|---|---|---|---|---|
| Price | $ 1.70 | $ 1.79 | $ 23.23 | $ 16.32 |
| Return | — | -5.03% | -92.68% | -89.58% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 11M | -$ 133M | $ 117M |
| 2025 | $ 11M | -$ 148M | $ 139M |
| 2024 | $ 9M | -$ 149M | $ 209M |
| 2023 | $ 34M | -$ 102M | $ 328M |
| 2022 | $ 13M | -$ 99M | $ 247M |
| IPO2021 | $ 9M | -$ 66M | $ 375M |
Explore beyond CRBU
You're looking at Caribou Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
